$A mathematical model of the impact of novel treatments on the A\03B2 burden in the Alzheimer's brain, CSF and plasma$

A mathematical model of the impact of novel treatments on the A\03B2 burden in the Alzheimer's brain, CSF and plasma

Title from cover.

Bibliographic Details
Main Authors:	Wein, Lawrence M., Craft, David Lee, Selkoe, Dennis J.
Other Authors:	Sloan School of Management.
Format:	Working Paper
Published:	[Cambridge, Mass. : Alfred P. Sloan School of Management, Massachusetts Institute of Technology] 2009
Online Access:	http://hdl.handle.net/1721.1/48375

Similar Items

The impact of novel treatments on A\03B2 burden in Alzheimer's Disease : insights from a mathematical model
by: Craft, David Lee., et al.
Published: (2009)

The influence of insulin resistance on CSF and plasma biomarkers of Alzheimer’s pathology
by: Westwood, S, et al.
Published: (2017)

Decreased CSF acetylcholinesterase activity in Alzheimer's disease.
by: Appleyard, M, et al.
Published: (1983)

CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease
by: Delvenne, A, et al.
Published: (2024)

Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer's disease multimodal biomarker discovery cohort
by: Westwood, S, et al.
Published: (2020)

A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer’s disease
by: Ashton, NJ, et al.
Published: (2019)

The increasing burden of Alzheimer disease.
by: Sadik, K, et al.
Published: (2003)

Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease.
by: Combrinck, M, et al.
Published: (2006)

Inflammation-related plasma and CSF biomarkers for multiple sclerosis
by: Huang, J, et al.
Published: (2020)

Analysing the effect of CSF inflammatory proteins on stroke severity in people with varying severities of Alzheimer's disease
by: Chan, Shawn Kiat Zhong
Published: (2023)

Response to treatment with TNFα inhibitors in rheumatoid arthritis is associated with high levels of GM-CSF and GM-CSF(+) T lymphocytes
by: Bystrom, J, et al.
Published: (2017)

Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers
by: Nho, K, et al.
Published: (2018)

Discovery of plasma biomarkers related to blood-brain barrier dysregulation in Alzheimer's disease
by: Dan Yuet Ruh
Published: (2024)

Alzheimer's brain changes
by: Cheah, Pike See, et al.
Published: (2016)

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
by: Shi, L, et al.
Published: (2019)

Characterization of the function and expression of the murine granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor with a novel GM-CSF fusion protein
by: Rosas, M, et al.
Published: (2005)

ISOLATION OF YACS FOR CSF-1R AND CSF-1 AND GENE LOCALIZATION USING FISH
by: Boultwood, J, et al.
Published: (1992)

Herpesviruses in brain and Alzheimer's disease.
by: Lin, W, et al.
Published: (2002)

Mathematical modelling and inference for Alzheimer’s Disease
by: Chaggar, P
Published: (2024)

CSF ELECTROPHORESIS IN 1000 PATIENTS
by: Ebers, G
Published: (1980)

Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease.
by: Kim, M, et al.
Published: (2016)

Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.
by: Nobili, F, et al.
Published: (2002)

Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and CSF
by: Winchester, L, et al.
Published: (2022)

Inflammatory biomarkers in Alzheimer's disease plasma
by: Morgan, A, et al.
Published: (2019)

Treatment for Alzheimer's disease.
by: Wilcock, G
Published: (2000)

Plasma protein biomarkers for the prediction of CSF amyloid and tau and [18F]-flutemetamol PET scan result
by: Westwood, S, et al.
Published: (2018)

CSF electrophoresis in one thousand patients.
by: Ebers, G, et al.
Published: (1980)

CNS barriers and modern CSF diagnostics /
by: Felgenhauer, Klaus, et al.
Published: (1993)

Sweet's syndrome and neutrophilic panniculitis associated with G-CSF treatment in a patient with myelodysplasia
by: Brown, V, et al.
Published: (2008)

Finite element simulation of a poroelastic model of the CSF system in the human brain during an infusion test
by: Eisenträger, A, et al.
Published: (2012)

A network aggregation model for amyloid-β dynamics and treatment of Alzheimer’s diseases at the brain scale
by: Brennan, GS, et al.
Published: (2025)

Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment
by: Douaud, G, et al.
Published: (2013)

Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment.
by: Douaud, G, et al.
Published: (2013)

Perspectives of Alzheimer's disease treatments.
by: Davis, J, et al.
Published: (2008)

Clioquinol for the treatment of Alzheimer's Disease.
by: Jenagaratnam, L, et al.
Published: (2006)

GALANTHAMINE AND THE TREATMENT OF ALZHEIMERS-DISEASE
by: Wilcock, G, et al.
Published: (1993)

Anatomical analysis of brain MRI in Alzheimer’s disease
by: Farzan, Ali, et al.
Published: (2014)

Imaging the progression of Alzheimer pathology through the brain
by: Smith, A
Published: (2002)

Imaging the progression of Alzheimer pathology through the brain.
by: Smith, A
Published: (2002)

Brain chains as topological signatures for Alzheimer’s disease
by: Goodbrake, C, et al.
Published: (2024)